New studies aimed at identifying whether ALS patients have higher levels of truncated TrkB receptors and whether mutations in the TDP-43 and FUS genes affect TrkB splicing should help clarify this issue. Here, NTRK2 is linked to amyotrophic lateral sclerosis.